Transgenic technologies offer many scientific advantages in breeding for improved horticultural crop quality and performance. These proceedings describe multiple transgenic approaches to solving important agricultural constraints in horticultural crop production. However, very few genetically engineered horticultural crops have been released to farmers, either in the United States or overseas. This paper outlines some of the challenges in pursuing development of a transgenic crop beyond the laboratory research phase.
INTRODUCTION
In the first decade of commercial planting of transgenic crop varieties (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) , farmers around the world rapidly adopted the technology when offered the choice (James, 2006; Sankula et al., 2005) . Thus far, however, commercial availability of transgenic crops has been limited mostly to bulk commodities (corn, soybean, cotton and canola) and farmer-preferred traits (insect resistance and herbicide tolerance). Based on the results of current research, future biotechnology products could include a wider range of crops -including horticultural varieties and developing country staples -with innovative traits offering compelling consumer and environmental benefits, e.g. broadspectrum disease resistance, nutritional enhancement, drought tolerance. However, converting research results into commercial products remains a global challenge for the plant science community.
Despite the potential for widespread public good benefits from agricultural biotechnology, regulatory and market acceptance barriers can reduce commercial incentives to translate promising research results into farmer-ready transgenic varieties. Product development for a new genetically engineered crop variety in the United States can routinely require 10-15 years or more. Beyond the laboratory research phase, product developers must consider glasshouse and field testing, regulatory approvals (Table I) and breeding of farmer-preferred varieties. Public sector plant science researchers have usually shied away from such product-focused biotechnology research, and with the uncertainties of market acceptance and commercial returns, the private sector is generally reluctant to invest in product development for horticultural biotechnology crops serving niche markets. The challenges of biotechnology product development are compounded in developing countries, which often lack predictable regulatory systems and functioning seed sectors.
Nonetheless, the breadth of research presented in these proceedings makes it clear that public sector scientists are engaged in a wide spectrum of transgenic research projects aimed at solving important constraints on horticultural crop production. e.g. citrus canker, apple blight and banana black sigatoka. The scientists involved envision their research reaching farmers and markets. Where the incentives for private sector product development are lacking, we need to consider how best to strengthen biotechnology delivery pathways so that results from this research do indeed benefit growers and the larger public.
In this paper, we focus on three examples of research projects where USDA's Foreign Agricultural Service (FAS) is cooperating with other government agencies and donors to assist with foreign market access and international cooperation in agricultural biotechnology. The experiences of researchers and policymakers involved in these projects can guide future development of transgenic horticultural varieties.
PUBLIC SECTOR CASE STUDIES

Papaya
A public sector research team led by Dr. Dennis Gonsalves developed two cultivars of transgenic papaya resistant to Papaya ringspol virus (PRSV) for commercial release in 1998 (Gonsalves, D. et al., 2004) . Papaya growers in Hawaii, facing severe PRSV disease pressure, rapidly adopted the transgenic varieties (Gonsalves, C. et al., 2004) , and production levels stabilized and began to increase. The agronomic success of PRSV-resistant papaya has been well-documented; nevertheless, one remaining challenge is to ensure that papaya growers can sell their transgenic produce.
Following deregulation of PRS V-resistant papaya in the United States, transgenic papaya can be marketed and sold in Hawaii like any other fruit variety. However, overseas sales require approval from the importing country. FAS has been working with the researchers and the Hawaii Papaya Industry Association to gain regulatory approval for PRS V-resistant papaya in Japan, a major market for papaya exports. This process has been underway since 1998: a petition to the Japanese Ministry of Agriculture Fisheries and Forestry (MAFF) was approved in December 2000, while a second-tier review at the Ministry of Health, Labor and Welfare (MHLW) required additional molecular analysis, which the researchers have since generated. A finalized application will be submitted to MHLW in summer 2006, and environmental studies of the papaya in Japan are nearing completion. In the meantime, the researchers and industry partners are developing labeling and marketing strategies for the Japanese market and validating detection method protocols.
Plums
Dr. Ralph Scorza (USDA-Agricultural Research Service) and colleagues from laboratories in France, Poland, Romania, Spain and the Czech Republic, report in these proceedings on development, field testing and U.S. regulatory approval status of transgenic 'l-Joneysweet' (C5) plum trees resistant to Plum pox virus (PPV). In the United States, USDA is investing in this research as an insurance policy against future outbreaks of PPV disease, which is currently controlled in the United States by targeted stone-fruit tree eradication in infected regions of the East Coast. The international research partnership makes it possible to field test Honeysweet' in regions of Europe where PPV is already endemic. Since 1997, with support from their national and regional research funding bodies, partnering European scientists have obtained regulatory clearances for confined field testing of 'Honeysweet' in Poland, Romania, Spain and the Czech Republic. These field trials demonstrate effective, durable disease resistance. Once U.S. deregulation is completed, the European scientists plan to develop an application to the European Commission for regulatory approval to cultivate 'Honeysweet' in the European Union. This process may take some years.
Cassava
An international research team at the Donald Danforth Plant Science Center in St Louis, Missouri is partnering with scientists and research institutes from Nigeria, Kenya, Tanzania. Uganda and Malawi to develop virus-resistant varieties of the tropical root crop cassava. Several transgenic cassava lines showed highly increased resistance when artificially inoculated in the laboratory/glasshouse with the viruses that cause African cassava mosaic disease (Chellappan et al., 2004) . The next step is to evaluate how these transgenic cassava lines perform in field conditions where the disease is endemic. This requires field tests in Africa.
Applications to perform small scale field tests were prepared in partnership with institutions in Kenya, Nigeria and Malawi. in each of these countries, the biosafety review process includes an Institutional Biosafety Committee (IBC). a National Biosafety Committee (NBC) and a plant health regulatory authority. The United States Agency for International Development (USAID) funds these cassava research partnerships and also coordinates a regulatory peer review of the field trial design by international experts prior to issuing project approval.
Kenya has experience with several confined transgenic field trials, and in Spring 2003 began considering an application for virus-resistant cassava testing submitted by scientists from the Kenya Agricultural Research Institute. Following IBC and NBC discussions and submission of a revised application, the NBC decided to issue approval for a screenhouse trial rather than a field test in February 2004. That same month, the Kenya Plant Health Inspectorate Service (KEPHIS) approved an upgraded, fenced screenhouse site and 200 transgenic cassava plantlets were imported to Kenya, accompanied by the appropriate export and import permits. The plants were successfully established in the prepared screenhouse, and in adherence to the approved experimental design, remained confined until their oil-site destruction in Fall 2004. Inoculation experiments were conducted using disease-vector whiteflies collected from surrounding fields. However, the levels of inoculation achieved in the confined screenhouse were inadequate to draw conclusions regarding plant performance. Following completion of the screenhouse test, the Kenyan biosafety committees each met to consider the results. A new application for field testing was prepared and approved by the IBC. In September 2005, the NBC decided to require additional studies on the potential impact of transgenic cassava on local insect populations prior to approving a field test. Kenyan scientists are currently conducting these studies.
In Nigeria, an application for cassava field tests involving scientists from the International Institute for Tropical Agriculture and the National Root Crop Research Institute was approved by the biosafety committees of each institution in early 2004. The application was forwarded to the Nigerian NBC in April 2004. After some local training events, workshops and visits to the United States to study how field trials are conducted, the NBC met in October 2005 to consider the cassava application. Several questions were raised, which the scientists are in the process of answering prior to a future NBC meeting.
In Malawi, an application to conduct field tests was prepared by scientists from the Ministry of Agriculture and Food Security in Summer 2004. With the appropriate import and export permits, 100 non-transgenic tissue culture cassava plants were imported to Malawi so that local scientists could test soil transfer and hardening methods in preparation for transfer of similar transgenic plants. However, senior officials in the Ministry of Agriculture and Food Security have indicated that they do not wish to proceed with submission of the field test application at this time.
DISCUSSION
It is clear from these case studies that delivering transgenic horticultural crops to farmers and markets requires -at a minimum -perseverance on the part of the scientists involved. Each of the projects described is at a different stage in the product development cycle, and the challenges presented vary with the development stage and geographical region.
The first required step in moving beyond laboratory/glasshou se studies is early stage field testing. USDA's Animal and Plant Health Inspection Service (APHIS) regulates experimental field trials in the United States and issued permits for both the papaya and plum projects. Given the risk of re-introducing PPV. the U.S. plum field trials did not test for disease resistance. Instead, field resistance to PPV was studied in Europe, where the virus is en m m deic. Siilarl y . \ irus resistant cassava must be tested in field conditions with high natural disease pressure, as found in cassava-growing regions of Africa. However, biosafety regulatory systems in Africa are still developing, and at present the challenge of obtaining regulatory approval for an early-stage field trial is slowing down product development. In the United States, regulators first gained experience supervising field trials in 1985, and since that time APHIS has streamlined and simplified the approval process for small scale field tests. Hopefully, as African regulators also gain more experience with field testing transgenic crops, the difficulties of obtaining field test permits will lessen. In addition, political support from the highest levels of African governments will continue to be an important factor in promoting an enabling environment for local biotechnology development and access.
If early, proof-of-concept field testing yields promising results, larger scale field trials and development of a regulatory data package follow. The burden of the regulatory approvals system for wide environmental release of genetically engineered plants is frequently cited as a barrier to commercialization (Pew, 2004) . In the United States, a specialty crops initiative is exploring how best to obtain regulatory approval for transgenic specialty crops (including most horticultural crops) (Goldner et al., 2004) . Nonetheless, both transgenic papaya, and more recently transgenic plums, moved through the U.S. regulatory system without large research budgets typical of multinational corporations. The determined efforts and "can do" attitudes of the principal investigators were clearly critical.
In addition to early planning for regulatory review, public sector scientists must also consider licensing arrangements for proprietary technologies that may be needed to ensure freedom to operate. For the case studies described here, papaya and cassava both have freedom to operate in Hawaii and Africa respectively. Licensing issues are expected to be worked out shortly for transgenic plums to allow free access to the technology for stone-fruit breeders in the United States, following deregulation. There are encouraging developments in promoting public access to biotechnology through organizations such as the Public Intellectual Property Resource for Agriculture (http://www.pipra.org ) and BIOS (http://www.bios.net ).
The barriers to public acceptance of genetically engineered crops have been discussed extensively (e.g. Science and Development website). One of the factors cited by opponents of agricultural biotechnology is their aversion to multinational seed companies. Yet multiple examples of public sector biotechnology research are presented in these proceedings and have been documented elsewhere (Cohen, 2005) . Converting this research into improved farmer-ready plant varieties would demonstrate some of the broad public good benefits that can be derived from biotechnology. This in turn could play an important role in enhancing public acceptance and appreciation for the positive impacts of agricultural biotechnology.
Another challenge facing scientists who are working towards public release of transgenic varieties is that the academic culture at many universities and research institutes does not support product-focused biotechnology research. Several leading academic plant scientists have commented to the authors that such applied research is "away from the cutting edge", "not serious science", and best left to the private sector or international research centers in the CGIAR system. At the same time, the plant science research community promotes potential benefits to agriculture as a rationale for public investment in their research. Although researchers are quick to recognize the applicability of their laboratory results to agriculture, the task of translating that research into tangible products remains a global challenge. Debbie Delmer of the Rockefeller Foundation has pointed to the need for "translational research" that connects innovations in plant research to downstream applications (Delmer, 2005) , with a particular focus on the needs of the developing world. However, even in richer countries with well-developed public and private sector research systems, there are very few examples of transgenic horticultural crops reaching the market.
NEXT STEPS
Where incentives are low for the private sector to develop improved commercial plant varieties, how can we encourage public sector involvement in translational research? Perhaps we need first to recognize the public value of product-focused plant science, including the critical contributions of plant breeders. It then follows that hiring decisions, funding allocations and the content of training programs should allow space for more applied work alongside basic plant science research. Otherwise we run the risk that plant science research will be increasingly disconnected from and irrelevant to agriculture. The work presented in these proceedings offers the hope that, in time, research now underway will produce improved crops that reach markets.
FAS offers some support for international aspects of U.S.-based biotechnology research projects with the potential to increase international cooperation in agricultural biotechnology and address regulatory and market barriers to trade. The Technical Assistance for Specialty Crops (TASC) program is particularly relevant to horticultural researchers in the United States, and supported publication of these proceedings. Other recent examples of FAS support for agricultural biotechnology research include assistance with the application to approve transgenic papayas in Japan, a research coordination meeting for U.S. and European scientists working on 'Honeysweet' plums, and a study tour and internship for scientists and policymakers considering transgenic cassava field testing in East Africa. Researchers considering international aspects of applied biotechnology research are invited to consult the FAS website and/or the authors for further details.
